Related Tags >> Roche Genentech lung cancer FDA

Tarceva News

Most Popular Tarceva Story

Docs warned on Tarceva risks

May 12, 2009 — 11:51am ET | By Tracy Staton

In the latest of a series of new drug-safety warnings, the FDA has spotlighted the risk of intense side effects from the Roche/Genentech cancer therapy Tarceva. According to the agency, the drug has... Read more...

Tarceva Press Releases

Phase III Study (SATURN) Showed Tarceva Improved Progression-Free Survival as a First-Line Maintenance Therapy
Genentech, OSI Pharmaceuticals Announce Topline Results from Phase III Study Evaluating the Combination of Avastin and Tarceva
PRESS RELEASE: Tarceva approved for lung cancer in Japan

Latest Headlines

Docs warned on Tarceva risks
May 12, 2009
In cancer, it's AZ vs. Roche, Afinitor vs. everything
April 24, 2009
OSI sues Teva, Mylan for Tarceva patent infringement
March 20, 2009
Roche/Genentech file for broader Tarceva use
March 19, 2009
Roche cuts Tarceva price for U.K.
October 6, 2008
Tarceva linked with two patient deaths
September 24, 2008
Costs put cancer docs in financial bind
July 8, 2008
SPOTLIGHT: NICE rejects Roche drug as too costly
April 25, 2008
Roche, Cipla trade jabs on Tarceva
April 21, 2008
Court sends Mircera case to ITC
March 20, 2008
Thai official backs off licensing fight
March 11, 2008
ALSO NOTED: Wyeth wins FDA blessing for hemophilia med; India considers compulsory licensing;
February 22, 2008
ALSO NOTED: Japan to get Roche's Tarceva next week; Barr sues two generics makers over Seasonale;
December 14, 2007
ALSO NOTED: Tarceva gets Japan's nod; FDA blesses Novartis arthritis remedy;
October 22, 2007
Roche cuts UK price on cancer drug
October 3, 2007

Paid Research Reports

More Research Reports >>